🔗 Share this article

Chancellor Reeves has revealed she is preparing "focused steps to address household expense challenges" in the upcoming financial statement.

Speaking to media outlets, she noted that lowering inflation is a shared task of both the administration and the central bank.

The UK's price growth is forecast to be the most elevated among the G7 advanced economies this calendar year and next.

Possible Energy Cost Measures

It is understood the administration could take action to reduce utility costs, such as by cutting the present 5% rate of VAT charged on energy.

An additional possibility is to reduce some of the regulatory levies presently added to household expenses.

Fiscal Constraints and Expert Predictions

The government will receive the latest report from the independent fiscal watchdog, the OBR, on Monday, which will clarify how much room there is for such actions.

The view from most economists is that Reeves will have to introduce tax increases or expenditure reductions in order to meet her voluntary fiscal targets.

Earlier on Thursday, analysis suggested there was a £22 billion shortfall for the Treasury chief to fill, which is at the lower end of forecasts.

"There's a joint task between the central bank and the administration to further reduce some of the drivers of inflation," the Chancellor told the BBC in the US capital, at the annual meetings of the IMF and global financial institution.

Tax Pledges and International Issues

While much of the focus has been on likely tax rises, the chancellor said the most recent information from the OBR had not altered her pledge to campaign commitments not to raise rates on income tax, VAT or social security contributions.

She attributed an "uncertain global environment" with increasing geopolitical and trade concerns for the Budget revenue measures, probably to be focused on those "most able to pay."

International Trade Tensions

Referring to worries about the United Kingdom's commercial links with the Asian nation she said: "The UK's security interests invariably are paramount."

Last week's declaration by Chinese authorities to strengthen trade restrictions on critical minerals and other resources that are essential for advanced tech production led US President Donald Trump to threaten an further 100% tariff on goods from the Asian country, increasing the possibility of an full-scale commercial conflict between the two global powers.

The American finance chief described China's action "economic coercion" and "a international production power grab."

Inquired about considering the US offer to join its dispute with China, the Chancellor said she was "extremely troubled" by Chinese measures and called on the Chinese government "to avoid restrictions and restrict access."

She said the action was "bad for the international commerce and causes additional challenges."

"It is my opinion there are fields where we should challenge China, but there are also important prospects to export to China's economy, including financial services and other areas of the economy. We've got to get that balance correct."

The Treasury chief also affirmed she was collaborating with G7 counterparts "on our own essential resources plan, so that we are more independent."

NHS Drug Pricing and Funding

The Chancellor also recognized that the cost the National Health Service spends on drugs could go up as a consequence of current talks with the US government and its drugs companies, in return for lower tariffs and capital.

A number of the biggest global drug companies have said recently that they are either halting or abandoning operations in the UK, with some blaming the insufficient payments they are receiving.

Last month, the government science advisor said the price the NHS spends on drugs would must rise to prevent firms and pharmaceutical investment leaving the UK.

The Chancellor told media: "It has been observed due to the payment system, that clinical trials, innovative medicines have not been offered in the UK in the manner that they are in other EU nations."

"Our aim is to guarantee that people receiving care from the NHS are can obtain the top essential treatments in the world. And so we are examining this situation, and... seeking to attract more funding into the UK."